Essential thrombocytosis transformed AML with TP53 mutations and its clinical implications
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Essential thrombocytosis transformed AML with TP53 mutations and its clinical implications ; volume:15 ; number:1 ; day:18 ; month:12 ; year:2024 ; pages:1-6 ; date:12.2024
Discover oncology ; 15, Heft 1 (18.12.2024), 1-6, 12.2024
- Creator
-
Si, Yang
Wang, Jiyuan
Hambly, Brett D.
Wang, Yuli
Zhang, Yanfang
Bao, Shisan
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s12672-024-01665-y
- URN
-
urn:nbn:de:101:1-2503010629216.920637018674
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:33 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Si, Yang
- Wang, Jiyuan
- Hambly, Brett D.
- Wang, Yuli
- Zhang, Yanfang
- Bao, Shisan
- SpringerLink (Online service)
Other Objects (12)
Detection of AML-specific TP53 mutations in bone marrow–derived mesenchymal stromal cells cultured under hypoxia conditions
Niclosamide combined to Azacitidine to target TP53-mutated MDS/AML cells
TP53 mutations in Romanian patients with colorectal cancer
Machine learning analysis of gene expression reveals TP53 Mutant-like AML with wild type TP53 and poor prognosis
Significance of targeting DNMT3A mutations in AML
Functional classification of TP53 mutations in acute myeloid leukemia
Expression signatures of TP53 mutations in serous ovarian cancers
Endometrial carcinomas with ambiguous histology often harbor TP53 mutations
Impact of TP53 mutations in Triple Negative Breast Cancer
Clinical implications of germline mutations in breast cancer: TP53
Modeling and therapeutic targeting of t(8;21) AML with/without TP53 deficiency
Prognostic and predictive value of TP53 mutations in pediatric medulloblastoma
Detection of AML-specific TP53 mutations in bone marrow–derived mesenchymal stromal cells cultured under hypoxia conditions
Niclosamide combined to Azacitidine to target TP53-mutated MDS/AML cells
TP53 mutations in Romanian patients with colorectal cancer
Machine learning analysis of gene expression reveals TP53 Mutant-like AML with wild type TP53 and poor prognosis
Significance of targeting DNMT3A mutations in AML
Functional classification of TP53 mutations in acute myeloid leukemia
Expression signatures of TP53 mutations in serous ovarian cancers
Endometrial carcinomas with ambiguous histology often harbor TP53 mutations
Impact of TP53 mutations in Triple Negative Breast Cancer
Clinical implications of germline mutations in breast cancer: TP53
Modeling and therapeutic targeting of t(8;21) AML with/without TP53 deficiency
Prognostic and predictive value of TP53 mutations in pediatric medulloblastoma
Detection of AML-specific TP53 mutations in bone marrow–derived mesenchymal stromal cells cultured under hypoxia conditions
Niclosamide combined to Azacitidine to target TP53-mutated MDS/AML cells
TP53 mutations in Romanian patients with colorectal cancer
Machine learning analysis of gene expression reveals TP53 Mutant-like AML with wild type TP53 and poor prognosis
Significance of targeting DNMT3A mutations in AML
Functional classification of TP53 mutations in acute myeloid leukemia
Expression signatures of TP53 mutations in serous ovarian cancers
Endometrial carcinomas with ambiguous histology often harbor TP53 mutations
Impact of TP53 mutations in Triple Negative Breast Cancer
Clinical implications of germline mutations in breast cancer: TP53
Modeling and therapeutic targeting of t(8;21) AML with/without TP53 deficiency